Virax Biolabs Group (VRAX) Stock Price, Quote, News & History

Virax Biolabs Group Ltd (VRAX) Stock Price, Quote, News & History

VRAXNASDAQ

Trade with Public

$0.1960

-0.0073-3.59%

At close: Mar 12, 5:00 PM EST

$0.2100

0.0147.14%

After Hours: 4:29 PM EST

Key Statistics

Open

$0.21

$0.20

Volume / Avg.

207.46K / 307.84K

Day Range

$0.19 - $0.21

52 Wk Range

0.19 - 1.58

Market Cap

$1.56M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.8%

Days to Cover

Recent Virax Biolabs Group Ltd News

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Virax Biolabs (VRAX) Stock Cools After Hours Following 75% Rally

VRAX shares fell 12.79% in after-hours trading following a $5 million private placement announcement.

Mohd Haider

Crude Oil Gains 1%; Macy's Reports Strong Q3 Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.41M

Investing Cash Flow (TTM)

-497.40K

Financing Cash Flow (TTM)

1.96M

Free Cash Flow (TTM)

-5.90M

Capital Expenditure (TTM)

-497.40K

Net Change in Cash (TTM)

-3.94M

Analyst Trends and Forecast

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$1.30M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

310.47

PB Ratio (TTM)

0.28

Earnings Yield % (TTM)

-600.10%

Earnings Yield % (FWD)

-118.05%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.72

Company Debt

Total Debt

$195.58K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$108.59K

Total Cash

$3.35M

Debt to Equity

0.10

Issuance of Debt (TTM)

-$108.59K

Repayment of Debt (TTM)

-$108.59K

Key Statistics

Open

$0.21

$0.20

Volume / Avg.

207.46K / 307.84K

Day Range

$0.19 - $0.21

52 Wk Range

0.19 - 1.58

Market Cap

$1.56M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.8%

Days to Cover

About

Sector

Health Care

Industry

Health Care Providers & Services

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and service...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Virax Biolabs Group (VRAX) stock?

You can purchase shares of Virax Biolabs Group (NASDAQ:VRAX) through any online brokerage.

View our list of the best stock brokerages

Who are Virax Biolabs Group (VRAX) competitors?

Other companies in Virax Biolabs Group’s space includes: Akso Health Group (NASDAQ:AHG), McKesson Corp (NYSE:MCK), Henry Schein Inc (NASDAQ:HSIC), Accendra Health Inc (NYSE:ACH) and Cencora Inc (NYSE:COR).

What is the forecast, or price target, for Virax Biolabs Group (VRAX) stock?

Virax Biolabs Group has a consensus price target of $1.00.

What is the current price for Virax Biolabs Group (VRAX)?

The stock price for Virax Biolabs Group (NASDAQ: VRAX) is $0.21 last updated March 12, 2026 at 4:29 PM EDT.

Does Virax Biolabs Group (VRAX) pay a dividend?

There are no upcoming dividends for Virax Biolabs Group.

When is Virax Biolabs Group (NASDAQ:VRAX) reporting earnings?

Virax Biolabs Group does not have any upcoming earnings scheduled.

Is Virax Biolabs Group (VRAX) going to split?

There is no upcoming split for Virax Biolabs Group.

What sector and industry does Virax Biolabs Group (VRAX) operate in?

Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

People Also Watch

Key Statistics

Open

$0.21

$0.20

Volume / Avg.

207.46K / 307.84K

Day Range

$0.19 - $0.21

52 Wk Range

0.19 - 1.58

Market Cap

$1.56M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.8%

Days to Cover

Recent Virax Biolabs Group Ltd News

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Virax Biolabs (VRAX) Stock Cools After Hours Following 75% Rally

VRAX shares fell 12.79% in after-hours trading following a $5 million private placement announcement.

Mohd Haider

Crude Oil Gains 1%; Macy's Reports Strong Q3 Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.41M

Investing Cash Flow (TTM)

-497.40K

Financing Cash Flow (TTM)

1.96M

Free Cash Flow (TTM)

-5.90M

Capital Expenditure (TTM)

-497.40K

Net Change in Cash (TTM)

-3.94M

Analyst Trends and Forecast

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$1.30M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

310.47

PB Ratio (TTM)

0.28

Earnings Yield % (TTM)

-600.10%

Earnings Yield % (FWD)

-118.05%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.72

Company Debt

Total Debt

$195.58K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$108.59K

Total Cash

$3.35M

Debt to Equity

0.10

Issuance of Debt (TTM)

-$108.59K

Repayment of Debt (TTM)

-$108.59K

Key Statistics

Open

$0.21

$0.20

Volume / Avg.

207.46K / 307.84K

Day Range

$0.19 - $0.21

52 Wk Range

0.19 - 1.58

Market Cap

$1.56M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.8%

Days to Cover

About

Sector

Health Care

Industry

Health Care Providers & Services

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry